Section Arrow
DNTH.NASDAQ
- Dianthus Therapeutics
Quotes are at least 15-min delayed:2025/09/03 18:55 EDT
After Hours
Last
 24.26
0 (0.00%)
Bid
24.25
Ask
24.29
High 24.26 
Low 23.82 
Volume 8976 
Regular Hours
Last
 24.26
+0.41 (+1.72%)
Day High 
24.805 
Prev. Close
23.85 
1-M High
25.41 
Volume 
318.94K 
Bid
24.25
Ask
24.29
Day Low
23.655 
Open
23.73 
1-M Low
18.08 
Market Cap 
767.69M 
Currency USD 
P/E 3.03 
%Yield -- 
10-SMA 23.83 
20-SMA 21.97 
50-SMA 20.69 
52-W High 32.27 
52-W Low 13.365 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.27/-4.15
Enterprise Value
768.86M
Balance Sheet
Book Value Per Share
9.42
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
6.24M
Operating Revenue Per Share
0.20
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PMNProMIS Neurosciences0.4574-0.0792-14.76%6.98PE
After Hours 0.4169 -0.0405 -8.85%
ADAPAdaptimmune Therapeutics plc0.0526-0.0052-9.00%-- 
After Hours 0.0536 +0.001 +1.90%
CARMCarisma Therapeutics0.3699-0.0701-15.93%-- 
After Hours 0.3515 -0.0184 -4.97%
ETHZETHZilla Corporation2.52-0.15-5.62%-- 
After Hours 2.5 -0.02 -0.79%
STTKShattuck Labs1.28+0.27+26.73%-- 
After Hours 1.27 -0.01 -0.78%
Quotes are at least 15-min delayed:2025/09/03 18:55 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.